Investigating a mechanism in astrocytes to prevent a common type of dementia.
Project 4 - Astrocytic KATP channels in LATE+HS
This study is looking at how a specific gene might affect important brain cells in people with a type of dementia called LATE+HS, with the hope of finding new treatments that could help improve their brain health.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10897081 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific gene variant affects astrocytes, which are crucial brain cells, in relation to a subtype of dementia known as LATE+HS. The study aims to explore the role of the ABCC9 gene, which is linked to brain metabolism and blood flow, and how its dysregulation may contribute to dementia. By analyzing human astrocyte samples, researchers will assess gene expression and its impact on brain function. The ultimate goal is to identify potential therapeutic targets using a well-tolerated drug that may help improve outcomes for patients with this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for LATE+HS, particularly those with a specific ABCC9 gene variant.
Not a fit: Patients with dementia types unrelated to LATE+HS or those without the ABCC9 gene variant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that prevent or mitigate the effects of a common subtype of dementia.
How similar studies have performed: Previous research has shown promise in targeting astrocytic mechanisms for dementia treatment, suggesting potential for success in this approach.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Nelson, Peter T. — University of Kentucky
- Study coordinator: Nelson, Peter T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.